Telix Pharmaceuticals TLX
NASDAQ TLX
$11.91 +0.17 (+1.45%)
As of: Sep 4, 2026 · 11:50 AM EDT

Telix Pharmaceuticals (TLX) Shares Outstanding (Entity) (2023 - 2025)

Analysis

Telix Pharmaceuticals (TLX) Shares Outstanding (Entity) (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 140.22 Bn 132.37 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 86.04 Bn 78.05 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.70 Bn 58.52 Bn 1.37 Bn -
4 Moderna 57.56 Bn 52.42 Bn 52.00 Mn 399.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - 214.24 Mn
6 BeOne Medicines 40.16 Bn 35.06 Bn 1.53 Bn 113.02 Mn
7 Alnylam Pharmaceuticals 35.63 Bn 32.32 Bn 992.69 Mn 133.73 Mn
8 Royalty Pharma 28.63 Bn 27.79 Bn - 575.00 Mn
9 Insmed 27.73 Bn 26.57 Bn 358.27 Mn 218.28 Mn
10 Telix Pharmaceuticals 4.03 Bn 3.74 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 338.78 Mn
Dec 31, 2024 334.72 Mn
Dec 31, 2023 323.73 Mn